Ruxolitinib vs Allogeneic SCT for Patients With Myelofibrosis According to Donor Availability (Q64790149)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ruxolitinib vs Allogeneic SCT for Patients With Myelofibrosis According to Donor Availability |
clinical trial |
Statements
Ruxolitinib Versus Allogeneic Stem Cell Transplantation for Patients With Myelofibrosis According to Donor Availability: A Prospective Phase II Trial (MMM 02 Study) (English)
0 references
21 December 2016
0 references
20 December 2019
0 references
155
0 references
18 year
0 references
70 year
0 references